Randomisierte kontrollierte Studie
Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial
Epilepsia · 20.11.2026
DOI: 10.1002/epi.70601 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, online erschienen am 20.11.2026. Verfasst von Saman Fatima und 1 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fatima, S., & Tripathi, M. (2026). Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial. Epilepsia. https://doi.org/10.1002/epi.70601
Vancouver
Fatima S, Tripathi M. Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial. Epilepsia. 2026. doi:10.1002/epi.70601
BibTeX
@article{Fatima2026,
author = {Fatima, Saman and Tripathi, Manjari},
title = {Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70601}
}
EUVIMED